1 Collaborative Drug Discovery – Standigm Case Study q Drug Hunting with AI: A Novel Drug Discovery Paradigm Stand ig m’ s revolutionary approach to drug discovery is aided by CDD Vault informatics platform The biggest asset for any drug discovery organization is the ability to access and analyze insightful, contextual, and actionable data, which then informs and underpins critical decision making. New technologies that embrace the ‘omics’ era – genomics, proteomics, transcriptomics, metabolomics, etc. – and high-throughput, high-content screening and assay techniques are generating vast amounts of data on disease mechanisms, drug targets, and drug compounds. But trying to analyze all this data ‘by hand’, using traditional techniques, results in considerable lost

Join for free to read